OPKO Health Gross Margin 2010-2024 | OPK

Current and historical gross margin for OPKO Health (OPK) over the last 10 years. The current gross profit margin for OPKO Health as of September 30, 2024 is %.
OPKO Health Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-09-30 $0.71B $0.18B 25.14%
2024-06-30 $0.72B $0.19B 26.08%
2024-03-31 $0.80B $0.26B 32.63%
2023-12-31 $0.86B $0.32B 36.81%
2023-09-30 $0.87B $0.33B 37.95%
2023-06-30 $0.87B $0.31B 35.94%
2023-03-31 $0.91B $0.30B 33.08%
2022-12-31 $1.00B $0.29B 28.69%
2022-09-30 $1.22B $0.34B 27.95%
2022-06-30 $1.43B $0.45B 31.70%
2022-03-31 $1.56B $0.49B 31.19%
2021-12-31 $1.77B $0.58B 32.86%
2021-09-30 $1.87B $0.65B 34.80%
2021-06-30 $1.91B $0.66B 34.71%
2021-03-31 $1.77B $0.65B 36.86%
2020-12-31 $1.44B $0.54B 37.70%
2020-09-30 $1.16B $0.45B 38.40%
2020-06-30 $0.97B $0.38B 39.27%
2020-03-31 $0.89B $0.32B 36.18%
2019-12-31 $0.90B $0.33B 36.51%
2019-09-30 $0.90B $0.32B 35.48%
2019-06-30 $0.92B $0.33B 35.98%
2019-03-31 $0.96B $0.36B 37.89%
2018-12-31 $0.99B $0.39B 38.95%
2018-09-30 $0.93B $0.32B 34.19%
2018-06-30 $0.93B $0.31B 33.91%
2018-03-31 $0.96B $0.34B 35.08%
2017-12-31 $0.97B $0.35B 35.82%
2017-09-30 $0.98B $0.35B 36.27%
2017-06-30 $1.03B $0.41B 39.49%
2017-03-31 $1.09B $0.48B 43.50%
2016-12-31 $1.12B $0.51B 45.39%
2016-09-30 $1.22B $0.63B 51.39%
2016-06-30 $1.07B $0.56B 52.20%
2016-03-31 $0.75B $0.38B 50.66%
2015-12-31 $0.49B $0.26B 52.34%
2015-09-30 $0.24B $0.14B 57.26%
2015-06-30 $0.12B $0.07B 60.17%
2015-03-31 $0.10B $0.05B 54.00%
2014-12-31 $0.09B $0.04B 47.83%
2014-09-30 $0.09B $0.04B 44.83%
2014-06-30 $0.09B $0.04B 44.32%
2014-03-31 $0.09B $0.04B 44.32%
2013-12-31 $0.10B $0.05B 50.52%
2013-09-30 $0.09B $0.05B 51.09%
2013-06-30 $0.08B $0.04B 50.60%
2013-03-31 $0.07B $0.04B 50.72%
2012-12-31 $0.05B $0.02B 40.43%
2012-09-30 $0.04B $0.01B 37.84%
2012-06-30 $0.03B $0.01B 40.63%
2012-03-31 $0.03B $0.01B 43.33%
2011-12-31 $0.03B $0.01B 42.86%
2011-09-30 $0.03B $0.02B 62.07%
2011-06-30 $0.03B $0.02B 60.71%
2011-03-31 $0.03B $0.02B 59.26%
2010-12-31 $0.03B $0.02B 53.57%
2010-09-30 $0.02B $0.01B 36.84%
2010-06-30 $0.02B $0.01B 33.33%
2010-03-31 $0.01B $0.00B 30.00%
2009-12-31 $0.00B $0.00B 50.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.106B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $219.062B 26.20
Intuitive Surgical (ISRG) United States $209.612B 96.16
Alcon (ALC) Switzerland $45.206B 30.25
Edwards Lifesciences (EW) United States $41.870B 26.59
IQVIA Holdings (IQV) United States $38.108B 20.48
IDEXX Laboratories (IDXX) United States $37.713B 43.16
DexCom (DXCM) United States $34.497B 51.95
Mettler-Toledo (MTD) United States $28.642B 32.97
Waters (WAT) United States $24.401B 36.08
STERIS (STE) Ireland $22.253B 25.33
SONOVA HOLDING (SONVY) Switzerland $20.160B 0.00
Hologic (HOLX) United States $14.774B 15.85
Fresenius Medical Care AG KGaA (FMS) Germany $14.260B 14.64
Globus Medical (GMED) United States $11.976B 30.33
Sysmex ADR (SSMXY) Japan $11.771B 36.91
Penumbra (PEN) United States $10.036B 98.31
Masimo (MASI) United States $9.638B 46.64
Glaukos (GKOS) United States $8.562B 0.00
Teleflex (TFX) United States $8.064B 12.86
Integer Holdings (ITGR) United States $4.726B 26.79
Inari Medical (NARI) United States $4.676B 0.00
PROCEPT BioRobotics (PRCT) United States $3.694B 0.00
Veracyte (VCYT) United States $3.371B 101.16
Nihon Kohden (NHNKY) Japan $2.700B 14.76
LivaNova (LIVN) United Kingdom $2.605B 15.04
TransMedics (TMDX) United States $2.467B 78.19
Tandem Diabetes Care (TNDM) United States $2.413B 0.00
Elekta AB (EKTAY) Sweden $2.332B 20.97
Integra LifeSciences Holdings (IART) United States $2.008B 10.49
Alphatec Holdings (ATEC) United States $1.620B 0.00
RxSight (RXST) United States $1.353B 0.00
Pulse Biosciences (PLSE) United States $1.340B 0.00
Artivion (AORT) United States $1.311B 86.86
Paragon 28 (FNA) United States $1.088B 0.00
AxoGen (AXGN) United States $0.807B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.781B 13.27
IRadimed (IRMD) United States $0.778B 42.03
Mesa Laboratories (MLAB) United States $0.770B 16.83
SiBone (SIBN) United States $0.725B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.706B 0.00
Treace Medical Concepts (TMCI) United States $0.640B 0.00
OrthoPediatrics (KIDS) United States $0.574B 0.00
Delcath Systems (DCTH) United States $0.526B 0.00
ClearPoint Neuro (CLPT) United States $0.521B 0.00
Semler Scientific (SMLR) United States $0.463B 24.35
AngioDynamics (ANGO) United States $0.449B 0.00
Pacific Biosciences Of California (PACB) United States $0.438B 0.00
Tactile Systems Technology (TCMD) United States $0.412B 22.30
NeuroPace (NPCE) United States $0.408B 0.00
CVRx (CVRX) United States $0.357B 0.00
Accuray (ARAY) United States $0.277B 0.00
Inogen (INGN) United States $0.258B 0.00
Alpha Tau Medical (DRTS) Israel $0.226B 0.00
Anteris Technologies Global (AVR) Australia $0.222B 0.00
KORU Medical Systems (KRMD) United States $0.222B 0.00
Nevro (NVRO) United States $0.214B 0.00
Sight Sciences (SGHT) United States $0.138B 0.00
Rapid Micro Biosystems (RPID) United States $0.133B 0.00
LENSAR (LNSR) United States $0.126B 0.00
Hyperfine (HYPR) United States $0.125B 0.00
Spectral Diagnostics (EDTXF) Canada $0.118B 0.00
Neuronetics (STIM) United States $0.108B 0.00
Atossa Genetics (ATOS) United States $0.101B 0.00
Sensus Healthcare (SRTS) United States $0.100B 15.20
Monogram Orthopaedics (MGRM) United States $0.095B 0.00
EDAP TMS S.A (EDAP) France $0.092B 0.00
908 Devices (MASS) United States $0.089B 0.00
Vicarious Surgical (RBOT) United States $0.081B 0.00
InspireMD (NSPR) Israel $0.068B 0.00
Covalon Technologies (CVALF) Canada $0.061B 31.57
Lucid Diagnostics (LUCD) United States $0.057B 0.00
EnVVeno Medical (NVNO) United States $0.055B 0.00
Positron (POSC) United States $0.053B 0.00
Microbot Medical (MBOT) United States $0.044B 0.00
Baird Medical Investment Holdings (BDMD) $0.039B 0.00
Spectral AI (MDAI) United States $0.037B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Accelerate Diagnostics (AXDX) United States $0.032B 0.00
WORK Medical Technology Group (WOK) China $0.032B 0.00
Envoy Medical (COCH) United States $0.032B 0.00
NexGel (NXGL) United States $0.023B 0.00
DarioHealth (DRIO) United States $0.021B 0.00
Adagio Medical Holdings (ADGM) United States $0.017B 0.00
Biosig Technologies (BSGM) United States $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.012B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.011B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Aspira Women's Health (AWH) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Tenon Medical (TNON) United States $0.005B 0.00
T2 Biosystems (TTOO) United States $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Avinger (AVGR) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00